The aim of this research was to evaluate the interference of the association of different types
of nutritional diet in the anti-inflammatory and analgesic activities of etoricoxib in in vivo …

This study has evaluated the anti-inflammatory and analgesic responses of etoricoxib, a
selective COX-2 non-steroidal anti-inflammatory drug combined with misoprostol in pre …

Celecoxib is a frequently used nonsteroidal anti-inflammatory drug (NSAID) in the treatment
of rheumatoid arthritis and osteoarthritis. It selectively inhibits cyclooxygenase II (COX-2) …

In 5 random groups of Wistar rats (n= 15 for each group), ulcerogenic doses of NSAIDs COX-
1-COX-2 inhibitors such as indomethacin were compared with Celecoxib (COX-2 inhibitor); …

Background and objectives: The clinical use of non-steroidal anti-inflammatory drugs is
limited due to high incidence of adverse drug reactions. The pyrrole heterocycle is included …

Selective COX-2 inhibitors have been shown to produce fewer gastrointestinal adverse
reactionsthan classical NSAIDs. Nevertheless, these new agents may worsen and delay the …

Non-Steroidal Anti-inflammatory drugs (NSAIDs) are widely employed in musculoskeletal
disease, both for their antiinflammatory as well as their analgesic properties [1]. Use of these …

Abstract Non-Steroidal Anti-inflammatory drugs (NSAIDs), including selective
cyclooxygenase (COX)-2 inhibitors, have come to play an important role in the …

The pharmacological profile of celecoxib (CAS 169590-42-5, SC-58635), a specific
cyclooxygenase-2 (COX-2) inhibitor, was investigated. Celecoxib inhibited COX-2-mediated …

Selective COX-2 inhibitor, celecoxib, delays the healing of gastric ulcers by inhibiting
prostaglandins synthesis. Therefore, the effect of celecoxib on normal and acid-challenged …